Overview

Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans

Status:
Withdrawn

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

This study will be an 8-week randomized, placebo-controlled clinical trial of pregnenolone administered adjunctively to treatment as usual in PTSD and depression in OEF/OIF Veterans.

Phase:

Phase 2

Details

Lead Sponsor:

US Department of Veterans Affairs
VA Office of Research and Development